Formosa Pharmaceuticals and AimMax Therapeutics announce NDA Submission to USFDA for APP13007
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder
Affordability is key to providing accessible healthcare for Bharat.
Launch of the Da Vinci Xi Robotic System is the highlight of the Robotic Colorectal Cancer Symposium organized with the Association of Colon and Rectal Surgeons of India
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
hubergroup’s two newly added medical vans are dedicated to dental and eye care
Women of all ages will get round-the-clock access to comprehensive treatment
Expands robotics to 20+ specialities
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Subscribe To Our Newsletter & Stay Updated